Sabine Doris Brookman-May

Prof. Dr. Sabine Doris Brookman-May


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in European Urology Focus
Verified
Journal Article
Closed access
SBSabine Doris Brookman-May
Sabine Doris Brookman-May
RCRiccardo Campi
Riccardo Campi
JHJose D.S. Henríquez
Jose D.S. Henríquez
TKTobias Klatte
Tobias Klatte
JLJohan F. Langenhuijsen
Johan F. Langenhuijsen
AMAndrea Minervini
Andrea Minervini

1 September 2013 in European Urology
Verified
Journal Article
Closed access
SBSabine Doris Brookman-May
Sabine Doris Brookman-May
MMMatthias May
Matthias May
SSShahrokh F Shariat
Shahrokh F Shariat
EXEvanguelos Xylinas
Evanguelos Xylinas
CSChristian Stief
Christian Stief
MPMembers Of The Corona Project And The Saturn Project
Members Of The Corona Project And The Saturn Project

23 May 2013 in BJU International
Verified
Journal Article
Open access
PDF file
SBSabine Doris Brookman-May
Sabine Doris Brookman-May
MMMatthias May
Matthias May
SSShahrokh F. Shariat
Shahrokh F. Shariat
GNGiacomo Novara
Giacomo Novara
RZRichard Zigeuner
Richard Zigeuner
MGMembers of the CORONA‐Project, the SATURN‐Project, and the Young Academic Urologists Renal Cancer Group
Members of the CORONA‐Project, the SATURN‐Project, and the Young Academic Urologists Renal Cancer Group
Objectives: To assess the prognostic impact of time to recurrence ( TTR ) on cancer‐specific survival ( CSS ) after recurrence in patients with renal cell carcinoma ( RCC ) undergoing radical nephrectomy or nephron‐sparing surgery. To analyse differences in clinical and histopathological criteria between patients with early and late recurrence. Patients and Methods: Of 13 107 patients with RCC from an international multicentre database, 1712 patients developed recurrence in the follow‐up ( FU ), at a median (interquartile range) of 50.1 (25–106) months. In all, 1402 patients had recurrence at ≤5 years (Group A) and 310 patients beyond this time (Group B ). Differences in clinical and histopathological variables between patients with early and late recurrence were analysed. The influence of TTR and further variables on CSS after recurrence was assessed by Cox regression analysis. Results: Male gender, advanced age, tumour diameter and stage, Fuhrman grade 3–4, lymphovascular invasion ( LVI ), and pN + stage were significantly more frequent in patients with early recurrence, who had a significantly reduced 3‐year CSS of 30% compared with patients in Group B (41%; P = 0.001). Age, gender, tumour histology, pT stage, and continuous TTR (hazard ratio 0.99, P = 0.006; monthly interval) independently predicted CSS . By inclusion of dichotomised TTR in the multivariable model, a significant influence of this variable on CSS was present until 48 months after surgery, but not beyond this time. Conclusions: Advanced age, male gender, larger tumour diameters, LVI , Fuhrman grade 3–4, pN + stage, and advanced tumour stages are associated with early recurrence. Up to 4 years from surgery, a shorter TTR independently predicts a reduced CSS after recurrence.

1 July 2018 in European Urology
Verified
Journal Article
Closed access
KMKurt Miller
Kurt Miller
JCJoan Carles
Joan Carles
JGJürgen E. Gschwend
Jürgen E. Gschwend
HPHendrik Van Poppel
Hendrik Van Poppel
JDJoris Diels
Joris Diels
SBSabine Doris Brookman-May
Sabine Doris Brookman-May